Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Recent analysis of case-control studies indicates that NSAIDs are associated with higher rates of complications following respiratory tractinfections, including complicated pneumonia, pleural effusions, chronic disease, peritonsillary abscess, spread or suppuration of infection to more than one site [34]. NSAIDs have also been associated with delays in prescribing effective antibiotic treatment to patients requiring admission to hospital. The Food and Drug Administration (FDA) has released a statement on the use of non- anti- drugs (NSAIDS) in patients with 2019-nCoV. There are insufficient clinical evidences to link the use of NSAIDs in worsening COVID-19 symptoms, according to the agency [35].